Trial Profile
A Retrospective study to evaluate the Clinical Outcomes of Biosimilar Follitropin Alfa (Bemfola ®) comapared to the established recombinant FSH preparations [Follitropin Alfa (Gonal-f) or Follitropin Beta (Puregon)] for Controlled Ovarian Stimulation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2018
Price :
$35
*
At a glance
- Drugs Follitropin alfa (Primary) ; Follitropin beta
- Indications Female infertility
- Focus Therapeutic Use
- 23 Oct 2018 New trial record
- 10 Oct 2018 Results presented at the American Society for Reproductive Medicine Scientific Congress 2018